InvestorsHub Logo
Followers 8
Posts 481
Boards Moderated 0
Alias Born 02/03/2021

Re: HyGro post# 205628

Sunday, 03/13/2022 10:07:19 PM

Sunday, March 13, 2022 10:07:19 PM

Post# of 233765
ANVISA approved the cd16/17 trials based on what they saw in cd12. Explain why they gave us two trials focused on very severe to critical patients and with 4 doses, if all they saw in cd12 is the gloom and doom you are picturing. If cd12 was total failure to be summarily dismissed of merit, what else is the independent basis for ANVISA to accept our proposed trials and allow the recruiting of their suffering citizens?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News